|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received September 27, 2004
Revised October 25, 2004
Accepted after revision November 30, 2004
1 Vanderbilt University
* To whom correspondence should be addressed. E-mail: patrick.fueger{at}duke.edu.
The aim was to test whether in fact glucose transport is rate-limiting in control of muscle glucose uptake (MGU) under physiological hyperinsulinemic conditions in the conscious, unrestrained mouse. C57Bl/6J mice overexpressing GLUT4 (GLUT4Tg), hexokinase II (HKTg), or both (GLUT4Tg + HKTg) were compared to wild type (WT) littermates. Catheters were implanted into a carotid artery and jugular vein for sampling and infusions at 4 mo of age. After a
5 d recovery, 5 h fasted conscious mice underwent one of two protocols (n=8-14/group). Saline or insulin (4 mU/kg/min) was infused for 120 min. All mice received a bolus of 2 deoxy[3H]glucose (2DG) at 95 min. Glucose was clamped at ~165 mg/dl during insulin infusion and insulin levels reached ~80 µU/ml. 2DG rate of disappearance from the blood provided an index of whole body glucose clearance. Gastrocnemius, superficial vastus lateralis, and soleus were excised at 120 min to determine 2DG-6-phosphate and calculate an index of MGU (Rg). Results show that whole body and tissue specific indices of glucose utilization were 1) augmented by GLUT4 overexpression, but not HKII overexpression, in the basal state; 2) enhanced by HKII overexpression in the presence of physiological hyperinsulinemia; and 3) largely unaffected by GLUT4 overexpression during insulin clamps whether alone or combined with HKII overexpression. Therefore, while glucose transport is the primary barrier to MGU under basal conditions, glucose phosphorylation becomes a more important barrier during physiological hyperinsulinemia in all muscles. The control of MGU is distributed rather than confined to a single rate-limiting step such as glucose transport since glucose transport and phosphorylation can both become barriers to skeletal muscle glucose influx.
This article has been cited by other articles:
![]() |
N. Raychaudhuri, S. Raychaudhuri, M. Thamotharan, and S. U. Devaskar Histone Code Modifications Repress Glucose Transporter 4 Expression in the Intrauterine Growth-restricted Offspring J. Biol. Chem., May 16, 2008; 283(20): 13611 - 13626. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ranalletta, X. Q. Du, Y. Seki, A. S. Glenn, M. Kruse, A. Fiallo, I. Estrada, T.-S. Tsao, A. E. Stenbit, E. B. Katz, et al. Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1178 - E1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Fueger, R. S. Lee-Young, J. Shearer, D. P. Bracy, S. Heikkinen, M. Laakso, J. N. Rottman, and D. H. Wasserman Phosphorylation Barriers to Skeletal and Cardiac Muscle Glucose Uptakes in High-Fat Fed Mice: Studies in Mice With a 50% Reduction of Hexokinase II Diabetes, October 1, 2007; 56(10): 2476 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frosig, A. J. Rose, J. T. Treebak, B. Kiens, E. A. Richter, and J. F.P. Wojtaszewski Effects of Endurance Exercise Training on Insulin Signaling in Human Skeletal Muscle: Interactions at the Level of Phosphatidylinositol 3-Kinase, Akt, and AS160 Diabetes, August 1, 2007; 56(8): 2093 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Southworth, K. A. B. Davey, A. Warley, and P. B. Garlick A reevaluation of the roles of hexokinase I and II in the heart Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H378 - H386. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Wasserman and P. T. Fueger Point-Counterpoint: Glucose phosphorylation is/is not a significant barrier to muscle glucose uptake by the working muscle J Appl Physiol, December 1, 2006; 101(6): 1803 - 1805. [Full Text] [PDF] |
||||
![]() |
I. R. Bederman, D. A. Dufner, J. C. Alexander, and S. F. Previs Novel application of the "doubly labeled" water method: measuring CO2 production and the tissue-specific dynamics of lipid and protein in vivo Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E1048 - E1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Maddux, Y.-N. Chang, D. Accili, O. P. McGuinness, J. F. Youngren, and I. D. Goldfine Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E746 - E749. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |